IRIS
ROMANO, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.499
EU - Europa 3.365
AS - Asia 2.938
SA - Sud America 274
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 12
AN - Antartide 1
Totale 11.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.379
SG - Singapore 1.163
CN - Cina 838
IT - Italia 702
IE - Irlanda 471
UA - Ucraina 454
GB - Regno Unito 396
SE - Svezia 389
TR - Turchia 357
FR - Francia 306
IN - India 259
DE - Germania 231
BR - Brasile 222
FI - Finlandia 126
VN - Vietnam 109
RU - Federazione Russa 88
CA - Canada 75
PL - Polonia 51
HK - Hong Kong 45
KR - Corea 44
AT - Austria 43
MX - Messico 29
JP - Giappone 28
ZA - Sudafrica 25
NL - Olanda 24
ES - Italia 21
BD - Bangladesh 20
PE - Perù 18
AR - Argentina 15
EG - Egitto 15
BE - Belgio 14
CZ - Repubblica Ceca 14
IR - Iran 13
EU - Europa 11
IL - Israele 10
AU - Australia 9
BZ - Belize 9
PK - Pakistan 9
LT - Lituania 8
MA - Marocco 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
TW - Taiwan 5
ID - Indonesia 4
IQ - Iraq 4
PH - Filippine 4
RO - Romania 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
CO - Colombia 3
EE - Estonia 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
AL - Albania 2
EC - Ecuador 2
HR - Croazia 2
KE - Kenya 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KI - Kiribati 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 11.153
Salva come PNG Salva come JPEG
Città #
Singapore 839
Chandler 666
Jacksonville 517
Dublin 465
Dallas 279
Southend 268
Ashburn 257
Beijing 207
Princeton 207
Izmir 201
New York 161
Nanjing 132
Santa Clara 121
Dearborn 112
Los Angeles 110
The Dalles 110
Boardman 107
Chieti 101
Altamura 90
Wilmington 88
Cambridge 80
Ann Arbor 73
Tongling 66
Nanchang 63
Pescara 53
Rome 47
Buffalo 46
Seoul 37
Warsaw 36
Helsinki 35
Montesilvano 34
Montreal 34
Vienna 34
Hong Kong 32
Munich 30
San Mateo 29
Tokyo 27
Denver 26
São Paulo 26
Washington 26
Ho Chi Minh City 25
Houston 25
Hebei 24
Woodbridge 24
Hanoi 23
Redondo Beach 23
Tianjin 23
Dong Ket 22
Shenyang 22
Toronto 22
Brooklyn 21
Düsseldorf 21
Jiaxing 21
Kunming 21
Falls Church 20
Johannesburg 20
Nuremberg 20
Augusta 19
Hefei 18
Boston 17
Chicago 17
San Francisco 15
Stockholm 15
Brussels 14
Chennai 14
Cornaredo 14
Frankfurt am Main 14
Grevenbroich 14
London 14
Milan 14
Changsha 13
Poplar 13
Central 12
Cairo 11
Phoenix 11
Seattle 11
Turku 11
Ica 10
Mexico City 10
Mumbai 10
Orange 10
San Buono 10
Brno 9
Orem 9
Querétaro 9
Ascoli Piceno 8
Hangzhou 8
Jinan 8
Lima 8
New Delhi 8
Amsterdam 7
Atlanta 7
Lanzhou 7
Leawood 7
Manchester 7
Meylan 7
Norwalk 7
Paris 7
Piotrkow Trybunalski 7
Ancona 6
Totale 6.716
Salva come PNG Salva come JPEG
Nome #
Sistema di rilascio della lipossina A4 mediante membrana polimerica porosa ottenuta con elettrofilatura 320
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 186
Impiego di cellule staminali da legamento parodontale per lo screening farmacologico in fibrosi cistica. 178
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 174
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 172
Establishment and long-term culture of human cystic fibrosis endothelial cells 169
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 167
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 167
Mechanisms of endothelial cell dysfunction in cystic fibrosis 159
Pentraxin 3 and platelet activation in obese patients after gastric banding 155
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 152
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 149
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 144
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 141
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 135
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 134
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 133
Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology 131
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 130
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 128
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 126
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 126
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 125
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 123
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 123
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 122
Activation of human monocytes and the acute monocytic cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 and lipoxin B4: evidence for differential Ca2+ mobilization 120
Increased soluble CD40L levels in cystic fibrosis 120
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 119
Epigenetic regulation of the formyl peptide receptor 2 gene 118
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 115
Lipoxins, resolvins, and the resolution of inflammation 115
Lipoxin receptors 114
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 114
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 114
Leptin increase is associated with markers of the hemostatic system in obese healthy women 113
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 113
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 112
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 112
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 112
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 111
Diabetes mellitus during pregnancy interferes with the biological characteristics of wharton's jelly mesenchymal stem cells 111
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 111
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen 109
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 109
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 108
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics 106
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 106
Homocysteine modulates the CD40/CD40L system 105
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 105
Transcellular regulation of eicosanoids biosyntesis 102
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 101
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 99
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 99
Increased levels of soluble P-selectin in hypercholesterolemic patients 97
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 97
Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells 96
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 95
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders 94
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 94
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R 92
Induction of functional Lipoxin A4 receptors in HL-60 cells 92
Hepatocytes are a rich source of novel aspirin-trigged 15-epi-lipoxin A(4) 92
Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity 92
5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 90
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C 89
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 89
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 89
Lipoxin biosynthesis and actions: role of the human platelet LX-Synthase 88
Myelofibrosis: A role for Platelet Derived Growth Factor (PDGF) ? 88
Cyclooxygenase-2-derived lipoxin A(4) increases gastric resistance to aspirin-induced damage 88
Lipoxin and aspirin-triggered lipoxins 88
Reduced platelet mitogenic activity in myeloproliferative disorders 87
Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study 87
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells 87
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin 86
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer 85
Lipoxin synthase activity of human platelet 12-Lipoxygenase 85
Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy 85
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins 84
Ligand bias and its association with pro-resolving actions of melanocortin drugs 84
Human alveolar macrophages generate 15-HETE and can produce lipoxins 83
Peptido-leukotrienes stimulate von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells 82
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 82
Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip: Cystic fibrosis airway chip 82
The Resolution Approach to Cystic Fibrosis Inflammation 80
Lipoxin generation by human magakaryocyte-induced 12-lipoxygenase 79
Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity? 79
Inflammation resolution: does the bone marrow have a say? 79
Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study 79
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 78
Lipoxin generation by permeabilized human platelets 76
Fluticasone propionate reduces serum interleukin 8 in asthmatic patients 76
Endothelial perturbation in cystic fibrosis. 76
Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils 75
A Systematic Review on Organ-on-a-Chip in PDMS or Hydrogel in Dentistry: An Update of the Literature 74
Endotoxic Lipid A induces intracellular Ca2+ increase in human platelets 73
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 71
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 71
Lipoxin analogs and lipoxin formation in vivo 70
Totale 10.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021500 0 0 0 0 0 126 54 18 124 104 28 46
2021/2022600 9 14 4 145 26 16 10 39 38 39 81 179
2022/20231.804 130 246 111 213 183 327 86 144 234 26 50 54
2023/20241.011 78 46 49 30 57 294 185 51 19 46 22 134
2024/20252.229 130 381 319 83 81 97 78 118 246 92 267 337
2025/20262.062 321 211 461 560 462 47 0 0 0 0 0 0
Totale 11.560